Childhood cancers trials in France

In France 204 Also abroad 2459

204 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Dabrafenib and/or Trametinib Rollover Study
Where
Lyon, Nantes, Paris, Villejuif
Age
18 years to 100 years
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Le Kremlin-Bicêtre, Lyon, Marseille, Paris, Strasbourg, Villejuif
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 2Taking people
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Where
Marseille, Paris, Poitiers, Strasbourg
Age
1 year to 18 years
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07354074
Phase 2/3Taking people
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Where
Paris, Pessac
Age
12 years and over
People
340 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00
Phase 2Taking people
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
Age
12 years to 17 years
People
15 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07700758 · EU 2025-524515-37-00
No phaseTaking people
Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
Where
Clermont-Ferrand
Age
6 years to 18 years
People
300
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT03913962
Phase 4Taking people
Asciminib Roll-over Study
Where
Bordeaux, Caen Cedex 9, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes Cedex 1, Nice, Paris, Poitiers, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
No phaseNot yet taking people in France
Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
Where
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Rennes, Rouen, Saint-Denis, Saint-Etienne, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
Age
Up to 25 years
People
150
Run by
Institut Curie
See details and how to joinNCT07924384
Phase 2Not yet taking people in France
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
Where
Amiens Cedex 1, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Rennes, Saint-Etienne, St Denis, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
Age
Up to 17 years
People
50
Run by
Institut Curie
See details and how to join2024-515962-15-00 · EU 2024-515962-15-00
Phase 1Taking people
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Where
Marseille, Pierre-Bénite, Toulouse, Tours
People
225 worldwide
Run by
Janssen Cilag International
See details and how to join2026-525234-39-00 · EU 2026-525234-39-00
Phase 1/2Taking people
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Where
Lyon, Saint-Herblain, Toulouse Cedex 9, Villejuif
Age
12 years and over
People
840 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00
No phaseTaking people
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Where
Villejuif
Age
2 years and over
People
160
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05481502
Phase 3Taking people
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Where
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Nantes, Nîmes, Paris, Saint-Herblain, Toulouse, Vandœuvre-lès-Nancy, Villejuif
People
200 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00
Phase 1/2Taking people
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Bordeaux, Villejuif
Age
6 months to 30 years
People
65 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05533775
Phase 1/2Taking people
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Bordeaux, Villejuif
Age
Up to 17 years
People
37 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00
Phase 1/2Taking people
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Where
Besançon, Marseille, Nantes, Paris, Pierre-Bénite, Strasbourg, Strasbourg Cedex 2, Toulouse, Tours, Vandoeuvre Les Nancy, Villejuif
Age
2 years and over
People
420 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00
No phaseTaking people
Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
Where
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris, Rennes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
Age
6 years to 14 years
People
130
Run by
Institut Claudius Regaud
See details and how to joinNCT06599879
Phase 2/3Taking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Creteil Cedex, Dijon, Lille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Rennes Cedex 9, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
People
1,541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Villejuif
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Paris, Villejuif
Age
1 month to 17 years
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00
No phaseTaking people
Met Non Small Cell Cancer Registry (MOMENT)
Where
Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
People
700 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891
Phase 1Taking people
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Where
Marseille, Villejuif
Age
24 months to 18 years
People
20 worldwide
Run by
ITM Solucin GmbH
See details and how to joinNCT06441331 · EU 2024-512831-66-00
No phaseTaking people
AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
Where
Saint-Affrique
People
120
Run by
AstraZeneca
See details and how to joinNCT06548152
No phaseTaking people
Menin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia
Where
Strasbourg
Age
0 years to 17 years
People
10
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07898436
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00